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Abstract In normal epithelial cells, impaired cell-matrix
contact leads to induction of programmed cell death, a process
that has been termed ‘anoikis’. We investigated the role of p53
and other apoptotic proteins in anoikis in thyroid epithelial cells.
Western blot analysis demonstrated that neither p53 nor Bcl-2,
Bcl-XL and Bax protein expression changed during anoikis.
However, loss of endogenous p53 activity in cells transfected with
a dominant-negative mutated p53 inhibited anoikis demonstrat-
ing the involvement of p53-dependent processes. The phosphatase
inhibitor sodium orthovanadate opposed anoikis when added to
the cells within 6 h, suggesting a role for phosphorylated proteins.
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1. Introduction
Normal epithelial cells require attachment to the extracel-
lular matrix (ECM) to survive [1]. Normal epithelial cells
undergo a type of apoptosis named ‘anoikis’ when attachment
to ECM is denied, whereas the anchorage dependence is re-
duced or totally absent in transformed cells [2,3]. The re-
sponse to denied ECM attachment appears to be cell type-
speci¢c. While non-transformed primary ¢broblasts in suspen-
sion undergo cell cycle arrest, Myc/Ras and E1A/Ras trans-
formation sensitizes to apoptosis while Src transformation
renders ¢broblasts resistant to anoikis [4,5]. In contrast, trans-
formation renders epithelial cells resistant to this type of
apoptosis. It is now clear that some apoptotic pathways ini-
tiate at the cell surface from membrane receptors such as Fas/
APO1 and TNFR-1 and that the p53 tumor suppressor gene
plays a crucial role in some forms of apoptosis like that in-
duced by irradiation or following treatment with some chemo-
therapeutic compounds [6]. Recently, the p53 tumor suppres-
sor gene has been suggested to modulate survival of
transformed ¢broblasts and an immortalized mammary epi-
thelial cell line in suspension [4]. In Ha-ras-transformed mur-
ine embryonic ¢broblasts, Western blot analysis demonstrated
an increased p53 protein level after a few hours of culture in
suspension. We have shown that TAD-2, a human epithelial
cell line originated from normal fetal thyroid cells, is a suit-
able model to study thyroid cell-ECM interaction [7].
In the present study we demonstrate that thyroid epithelial
cells undergo apoptosis through a p53-dependent pathway
when integrin-mediated adhesion to ECM is denied, that it
is not induced by p53 over-expression itself nor by regulation
of Bcl-2, Bcl-XL or BAX, but rather it is dependent on phos-
phorylation events involving proteins others than p53 and
Bcl-2.
2. Materials and methods
2.1. Cell cultures and transfections
Immortalized human fetal thyroid cells (TAD-2) were generously
donated by Dr. T.F. Davies, Mount Sinai Hospital (New York, NY,
USA) and cultured in a 5% CO2 atmosphere at 37‡C, in RPMI me-
dium supplemented with 10% fetal calf serum (FCS). Medium was
changed every 3^4 days. Cells were detached by 0.5 mM EDTA in
calcium- and magnesium-free phosphate bu¡ered saline (PBS) with
0.05% trypsin. TAD-2 cells were transfected by calcium phosphate
precipitation with pRSVneo alone or with pLTRp53cG containing
the temperature-sensitive dominant-negative p53 gene mutated at co-
don 135 (gift of Dr. A. Levin, Princeton University, Princeton, NJ,
USA), generating several TAD53 cell clones. Stably transfected cell
were selected and grown with G-418 sulfate (Gibco BRL, Gaithers-
burg, MD, USA).
2.2. Estimation of apoptotic cells
Analysis of DNA fragmentation in cells undergoing anoikis was
performed as described previously in the same cell line [7] and the
percent apoptotic cells was determined by £ow cytometry. Brie£y,
cyto£uorimetric estimation of apoptosis was performed as follows:
£oating and adherent cells were trypsinized, collected and washed in
cold PBS. Cells were ¢xed in 70% cold ethanol for 30 min. Ethanol
was removed by two PBS washes and cells were incubated in PBS, 50
Wg/ml propidium iodide, 10 Wg/ml deoxyribonuclease-free ribonuclease
A for 1^3 h at 4‡C. Cells were then analyzed by £ow cytometry using
a FACScan (Becton Dickinson, Mountain View, CA, USA). The per-
cent apoptotic cells was calculated by dividing the number of cells
displaying red £uorescence lower than the G0-G1 diploid peak by
the total number of cellsU100.
2.3. Antibodies and Western blot analysis
Mouse monoclonal antibody to p53 was purchased from Transduc-
tion laboratories (Lexington, KY, USA); mouse monoclonal antibody
to Bcl-2 and rabbit polyclonal antibodies to Bcl-X and Bax were from
Santa Cruz Biotechnology, Santa Cruz, CA, USA. Cells were washed
in cold PBS and lysed for 10 min at 4‡C with 1 ml of lysis bu¡er (50
mM Tris, pH 7.4, 0.5% NP40, 0.01% SDS) containing protease inhib-
itors. Lysates from adherent cells collected by scraping and lysates
from £oating cells were centrifuged at 12 000Ug for 15 min at 4‡C.
The protein concentration in cell lysates was determined by Bio-Rad
Protein Assay (Bio-Rad, Richmond, CA, USA) and 50 Wg of total
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protein from each sample was boiled for 5 min in Laemmli sample
bu¡er (125 mM Tris pH 6.8, 5% glycerol, 2% SDS, 1% L-mercapto-
ethanol and 0.006% bromophenol blue). Proteins were separated by
SDS-polyacrylamide gel electrophoresis and transferred onto nitrocel-
lulose membrane (Hybond-ECL Nitrocellulose, Amersham, Rainham,
UK). Acrylamide concentration was 12% for p53 and Bcl-XL, 15%
for Bcl-2 and Bax. Membranes were blocked by 5% non-fat dry milk,
1% ovalbumin, 5% FCS and 7.5% glycine. and after three washes, the
membranes were incubated for 1 at 4‡C with 0.5 Wg/ml of mouse
monoclonal or rabbit polyclonal primary antibodies in PBS. After
three washes, ¢lters were incubated for 1 h at 4‡C with horseradish
peroxidase-conjugated anti-mouse or anti-rabbit secondary antibodies
(Bio-Rad) diluted 1:2000 in PBS, Tween-20. After a ¢nal wash, pro-
tein bands were detected by an enhanced chemiluminescence system
(Amersham). For quantitation, relative intensities of hybridization
signals were measured at 560 nm with a gel scan apparatus (PDI,
New York).
2.4. Statistics
Student’s t-test for paired samples was performed where indicated.
Di¡erences at P6 0.05 were considered statistically signi¢cant.
3. Results
3.1. E¡ect of inhibition of protein synthesis on anoikis
Some kinds of apoptosis require protein synthesis while
others do not and programmed cell death can even be accel-
erated by inhibitors of protein synthesis [8,9]. We therefore
investigated the e¡ect of the protein synthesis inhibitor cyclo-
heximide on anoikis of thyroid epithelial TAD-2 cells (Fig. 1).
A total of 5U105 adherent cells or cells in suspension in agar-
coated plates were incubated in the absence or in the presence
of 0.06 WM cycloheximide and apoptosis was determined by
£ow cytometry after 24, 48 and 72 h. This very low concen-
tration of cycloheximide was not toxic in adherent cells. In
cells maintained in suspension in the presence of cyclohex-
imide, inhibition of apoptosis reached approximately 80% at
48 h, then the e¡ect of cycloheximide became less evident,
giving 50% inhibition of anoikis at 72 h. Macromolecular
synthesis may be required to accomplish the apoptotic path-
way to achieve overexpression or de novo expression of pro-
apoptotic proteins, while in slow apoptosis, protein synthesis
could be required to maintain the steady state of apoptotic
proteins.
3.2. p53 is involved in suspension-induced apoptosis
p53 tumor suppressor gene is crucial in some but not all
forms of apoptosis. To determine whether p53 is required for
apoptosis to occur in thyroid cells lacking adhesion to ECM,
we stably transfected TAD-2 cells with a vector encoding a
temperature-sensitive murine p53 protein (p53cG) that dis-
plays a dominant-negative e¡ect at 39‡C and wild-type activ-
ity at 32‡C. Several TADp53cG stable cell clones were gen-
erated by G-418 selection of TAD-2 cells co-transfected with
pLTRp53cG and pRSVneo expression vectors. At 32‡C, over-
expression of the active form of p53cG determined cell death
in monolayer cultures, while proliferation curves of p53cG-
expressing cell mutants and control cells expressing only neo-
mycin (TADneo) cultured in adherent conditions at 39‡C were
identical (Fig. 2).
We then assayed the dominant-negative e¡ect of mutated
p53 expression in TADp53cG mutants at 39‡C. Various
TADp53cG clones and TADneo cells were treated for 24 h
at 39‡C with 70 Wg/ml of etoposide, a potent antineoplastic
drug that inhibits topoisomerase II and induces a p53-depend-
ent apoptosis in most cell types, and apoptosis was deter-
Fig. 1. E¡ect of cycloheximide on cell death induced by denied ad-
hesion. Cells in suspension in agar-coated plates were incubated in
the absence (b) or in the presence (a) of 0.06 WM cycloheximide
and apoptosis was determined by £ow cytometry at the indicated
times. Apoptosis in adherent cells was not induced by cycloheximide
at this low concentration (8). Results are reported as percent apop-
tosis from three separate experiments.
Fig. 2. Proliferation curves of TADneo (F), TADp53pool (a), and
TAD53-3 (b). The cells were seeded and cultured at 32‡C (left pan-
el) or at 39‡C (right panel). After 6 h the plates were washed to re-
move £oating cells and adherent cells were cultured in fresh me-
dium. At the indicated times, the number of cells in triplicate wells
was determined. The TAD53-4 clone is not reported in the diagram
because it was superimposed on TAD53-3.
Fig. 3. Involvement of p53 in suspension-induced apoptosis. A:
TADneo and TADp53 cell mutants were cultured for 24 h in the
presence of etoposide and apoptosis was estimated by £ow cytomet-
ric analysis. B, TADneo (b), TADp53-pool (F), TADp53-3 (a) and
TADp53-4 (E) were cultured in suspension for the indicated times
and apoptosis was determined.
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mined by £ow cytometry (Fig. 3A). TADneo cells were very
sensitive to etoposide, which induced apoptosis in 75% of the
cells, demonstrating that endogenous p53 was present and
that this cell line is sensitive to p53-dependent apoptosis.
TADp53cG mutants displayed up to 66% inhibition of etopo-
side-induced apoptosis, demonstrating inhibition of endoge-
nous p53 activity. TADp53cG mutants were cultured in sus-
pension for 72 h at 39‡C and apoptosis was determined (Fig.
3B). TADp53cG clones maintained in suspension displayed a
lower apoptosis, as compared to TADneo cells, demonstrating
that transcriptional activity of p53 is involved in anoikis.
3.3. Expression of p53, Bcl-2, Bax and Bcl-XL is not regulated
in anoikis
Western blot analysis of di¡erent pro- and anti-apoptotic
proteins was performed in thyroid cells cultured in a mono-
layer or in suspension onto agar-coated plates. Analysis of
protein expression within the ¢rst 3 h showed that both the
anti-apoptotic Bcl-2 protein and its transcriptional regulator
p53 were expressed in adherent cells at a constant level (Fig.
4). The level of these two proteins remained unchanged also
1 h and 3 h after transferring cells to suspension. Western blot
analysis of p53, Bcl-2, Bax and Bcl-XL was then extended to
TAD-2 cells cultured in monolayer or in suspension up to
48 h. Fig. 5 shows for each protein a representative immuno-
blot and the mean þ S.D. of densitometric analysis of four
independent experiments from 20 to 48 h. Clear expression
of p53 and Bcl-2 proteins was detectable in all samples. p53
and Bcl-2 protein expression was unchanged at all times in
both adherent and £oating cells undergoing apoptosis. Also a
shift of their molecular weight was not observed, indicating
that posttranslational modi¢cation of these two proteins did
not occur. Also Bcl-XL and Bax corresponding bands were
clearly visible by immunoblot. A slightly increased expression
of both proteins was detected after 36 h and 48 h of mono-
layer culture (Bcl-XL reached approximately a 1.8-fold and
Bax a 2.0-fold increase). In cells cultured onto agar-coated
plates and undergoing apoptosis, protein expression did not
change, always remaining at the lower level. These results
demonstrate that loss of adhesion to ECM does not induce
apoptosis through a variation of the level of p53 and proteins
under its transcriptional control (Bcl-2 and Bax) nor Bcl-XL.
3.4. Inhibition of endogenous phosphatases inhibits anoikis
To investigate whether phosphorylation events are required
for the execution of anoikis, we studied the e¡ect of the phos-
phatase inhibitor sodium orthovanadate on anoikis of thyroid
epithelial cells. TAD-2 cells in suspension were cultured in the
presence or absence of 50 WM sodium orthovanadate for 24,
48 and 72 h (Fig. 6A). The inhibitory e¡ect of sodium ortho-
vanadate was stronger at 24 h (57%) than at 48 h and only a
modest e¡ect was visible by 72 h of treatment (18%), indicat-
ing that sodium orthovanadate produced a delay of apoptosis.
We determined the time required by denied adhesion to trig-
ger an apoptotic pathway no more sensitive to orthovanadate.
Fig. 4. Western blot analysis of p53 and Bcl-2 expression in adher-
ent and suspended cells. TAD-2 cells were plated in uncoated or
agar-coated plates and cultured in full medium. After 1 h and 3 h,
adherent and suspended cells were collected and p53 and Bcl-2 ex-
pression was determined as described in Section 2. The level of both
proteins remained unchanged.
Fig. 5. Western blot analysis of p53, Bcl-2, Bcl-XL and Bax expres-
sion in adherent and suspended cells. TAD-2 cells were cultured in
uncoated or agar-coated plates for 20 h, 36 h and 46 h. Representa-
tive immunoblots of each protein are shown. Mean and standard
deviation of relative expression of each protein were also determined
by scanning densitometry of 3^5 immunoblots. In each diagram, a
value of 1 arbitrary unit was assigned to the highest density meas-
ured. *P6 0.05.
Fig. 6. E¡ect of sodium orthovanadate on anoikis. A: TAD-2 cells
were plated in agar-coated plates in the presence of 50 WM sodium
orthovanadate and percent apoptosis was determined by £ow cy-
tometry after the indicated times of culture. B: The cells were cul-
tured in suspension for 48 h in the presence of sodium orthovana-
date added to the cells immediately after plating or after 3, 6 or
14 h. Percent apoptosis was determined by £ow cytometry in three
independent experiments.
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Cells were cultured in suspension for 48 h in the presence of
50 WM sodium orthovanadate, added to the cells immediately
after plating or after di¡erent times (Fig. 6B). Flow cytometry
demonstrated that orthovanadate was unable to inhibit apop-
tosis when added 14 h after transferring the cells to suspen-
sion, thus indicating that at that time phosphorylation events
had ended their role and an execution pathway was activated.
4. Discussion
We previously showed that the TAD-2 cell line is a good
model to study anoikis in epithelial cell and that this cell line
is sensitive to both p53-independent apoptosis (lovastatin) [10]
and p53-dependent apoptosis (etoposide, present paper). Our
study indicates that, like in transformed ¢broblasts, in epithe-
lial thyroid cells an excess of wild-type-like p53 induced apop-
tosis whereas inactivation of endogenous p53 inhibited anoi-
kis. However, in contrast to transformed ¢broblasts [4],
modulation of p53 expression was not observed at any time
during anoikis, indicating that to accomplish its apoptotic
pathway, denied adhesion does not require variations of ex-
pression of p53 itself nor of p53-modulated apoptotic factors.
This di¡erence between ¢broblasts and epithelial cells may be
attributed to the di¡erent response to the microenvironment
of these two cell types, since transformation sensitizes ¢bro-
blasts to anoikis whereas it renders epithelial cells resistant [5].
As predicted by the observation that p53 expression was un-
changed, also Bcl-2 and Bax proteins, whose genes are known
to be under the transcriptional control of p53, remained con-
stant during apoptosis. Bcl-2, Bax and Bcl-XL, proteins be-
longing to the Bcl-2 family, constitute a critical intracellular
checkpoint of apoptosis. Homo- or heterodimerization of
these proteins, together with other members of the Bcl-2 fam-
ily, determines their availability to participate in apoptosis,
and the overall ratio of death agonists to antagonists dictates
the susceptibility to a death stimulus. Overexpression of Bcl-2
protects CHO cells from anoikis, demonstrating that although
modulation of the (Bcl-2, Bcl-XL)/Bax ratio does not occur in
thyroid cells, resetting of the Bcl-2 checkpoint also regulates
this type of apoptosis in epithelial cells [11].
Variation of protein expression is not the only mechanism
by which the Bcl-2 checkpoint can be reset and posttransla-
tional mechanisms also appear to be involved. Serine phos-
phorylation inactivates Bcl-2 in response to some apoptotic
stimuli [12,13], whereas hypophosphorylated Bad, a distantly
related Bcl-2 protein, heterodimerizes with Bcl-XL, neutraliz-
ing its protective e¡ect and promoting cell death [14,15]. The
data presented in our study support a critical role of phos-
phorylation in anoikis. The apoptotic factors involved are
other than Bcl-2 and p53 as Western blot analysis failed to
show a shift of molecular weight. Activated phosphoinositol
3-kinase (PI-3K) has been proposed to be involved in protec-
tion from di¡erent types of apoptosis, including anoikis. In
PC12 cells and in ¢broblasts, the PI-3K inhibitors wortman-
nin and LY294002 induce apoptosis, whereas constitutively
activated PI-3K or its target, the protein kinase B/Akt
(PKB/Akt), block anoikis in MDCK cells [16]. Thus, protein
kinases activated by ECM are candidates to transfer the signal
originated from the extracellular matrix to apoptotic factors,
thereby suppressing apoptosis and promoting cell survival. In
conclusion, our data indicate that anoikis in thyroid epithelial
cells is p53-dependent but it is not induced by p53 modulation
itself, whereas posttranslational modi¢cations of apoptotic
factors occur when cells are maintained in suspension, sug-
gesting a role for phosphorylation events in anoikis.
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